Results 91 to 100 of about 121,674 (149)

Innate immune cells in chimeric antigen receptor therapy. [PDF]

Mol Ther
Jassaud M, Ziane-Chaouche L, Duhamel M, Salzet M.   +3 more
europepmc   +1 more source

Chimeric Antigen Receptor T-Cell Therapy and Autoimmune Diseases in the Nervous System. [PDF]

Immun Inflamm Dis
Yao SY, Du MQ, Yang H, Zeng QM, Zhou H, Zhang X, Kazuo S, Liu J, Lin LX, Kang XH, Jiang DY, Peng Y.   +11 more
europepmc   +1 more source

Chimeric antigen receptor-based cell therapy for treating urological tumors. [PDF]

Curr Urol
Tang H, Guo L, Zhang W, Tang D.
europepmc   +1 more source

Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential. [PDF]

Mol Ther Oncol
Liao R, Chan CKW, Cui Y, Li S, Ma R, Peng D, Mei P, Xu M, Li P, Wong N.   +9 more
europepmc   +1 more source

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives. [PDF]

Oncol Res
Wang S, Wang M, Yao W.
europepmc   +1 more source

Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors. [PDF]

Front Immunol
Park JA, Cheung NV.
europepmc   +1 more source

Chimeric antigen receptor T cell therapy: Revolutionizing cancer treatment. [PDF]

World J Clin Oncol
Arjumand S, Raj A, Prattay KMR, Omer HBM, Azam F.   +4 more
europepmc   +1 more source

Chimeric antigen receptor (CAR) therapies for precise eradication of pathogenic cells in autoimmunity. [PDF]

Arthritis Res Ther
Kalliolias GD, Basdra EK, Papavassiliou AG.   +2 more
europepmc   +1 more source

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy. [PDF]

Int J Mol Sci
Cohen I, Lebel E, Grisariu S, Avni B, Kfir-Erenfeld S, Asherie N, Zimran E, Vainstein V, Assayag M, Sharon TD, Alexander-Shani R, Bessig N, Shehadeh A, Ishtay A, Schlossberg M, Pick M, Gatt ME, Bdolah-Abram T, Stepensky P, Elias S.   +19 more
europepmc   +1 more source

A global multidimensional analysis of the chimeric antigen receptor T-cell therapy clinical trial landscape and development trends. [PDF]

Biomark Res
Lai C, Hu J, Wu Z, He K, Li J, Zhu W, Liu C, He W, Xu K.   +8 more
europepmc   +1 more source